Physician profile
Peter Torrisi
NPI 1548286370
$1,645.29
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $148.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.62 | 2019-2020 | |
| Glaxosmithkline, LLC. | $233.83 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $217.67 | 2019-2020 | |
| Genentech USA, INC. | $200.24 | 2019 | |
| Grifols USA, LLC | $174.35 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $87.65 | 2019 | |
| Sunovion Pharmaceuticals INC. | $82.23 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $49.21 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $48.43 | 2019 | |
| Phadia US INC. | $47.54 | 2019 | |
| Gilead Sciences, INC. | $44.42 | 2019 | |
| Electromed, INC. | $37.99 | 2019 | |
| Insmed, INC. | $37.95 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.79 | 2019 | |
| Genzyme Corporation | $22.74 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $21.33 | 2020 | |
| Philips North America LLC | $17.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.90 | 2019 | |
| Mallinckrodt Enterprises LLC | $15.42 | 2019 | |
| Circassia INC. | $12.75 | 2019 | |
| Allergan, INC. | $11.61 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Torrisi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.